News

Avella Newsroom

January 1, 1970|
Avella Releases New Report on Anticipated Specialty Drug Approvals
April 27, 2018| CATEGORIES: Specialty Pharmacy , Press Release , limited distribution drugs

The leading specialty pharmacy has compiled insights about the specialty drug pipeline along with an analysis of the network distribution strategies for these medications.

Phoenix, AZ -- Avella has just announced the release of a 16-page report detailing the specialty drug pipeline, including all of the latest medications expected to receive FDA approval within the coming months. The 2018 Q2 Specialty Medication Pipeline Report provides at-a-glance information about all of these therapies including indications, approval status, anticipated costs, clinical considerations and therapeutic alternatives, among other key data points. It also provides helpful explanations of the various designations and approval processes undertaken by the FDA for specific types of medication such as orphan drugs and breakthrough therapies.

Avella to Improve Access to Naloxone, an Opioid Overdose-Reversing Medication, Through an Innovative New Program
April 24, 2018| CATEGORIES: Press Release , Pain Management , Addiction Management

The program’s launch will help further the Surgeon General’s efforts to encourage Americans
to carry this drug and help save lives.

Phoenix, AZ -- Avella has announced it will distribute naloxone, a powerful therapy used to treat opioid overdoses, as part of an innovative new program designed to improve access to the drug. The program allows individuals and family members in certain states to simply contact the pharmacy and order the drug by phone, with no physician prescription needed. In these circumstances, one of Avella’s pharmacists will actually supply the prescription if they determine that EVZIO® (naloxone HCl injection) or another naloxone therapy is appropriate. 

NCPDP Annual Conference Keynote Panel to Address “Data Challenges and Opportunities to Improve the Patient Journey”
April 17, 2018| CATEGORIES: Avella , Specialty Pharmacy , Press Mention

NCPDP announced today the Opening Keynote Panel for its 2018 Annual Technology & Business Conference, Industry United to Improve the Patient Journey, May 7-9, 2018, at the Westin Kierland Resort & Spa in Scottsdale, Arizona. The Keynote Panel will address “Data Challenges and Opportunities to Improve the Patient Journey,” on Tuesday, May 8, 2018. Avella founder and chairman of the board, John Musil, will participate on the panel representing specialty pharmacy.

LD Networks Shrinking; What Do You Need to Get In?
April 2, 2018| CATEGORIES: Specialty Pharmacy , Press Feature , limited distribution drugs

Many of today’s most effective specialty drugs are distributed through limited networks of specialty pharmacies, ranging in size from exclusive (one to two pharmacies) through limited small (two to five pharmacies) and limited large (six to 15 pharmacies). A new white paper from Avella Specialty Pharmacy reports that with 79.2% of manufacturers managing their specialty products through a limited distribution (LD) model, these LDs are shrinking even more, consisting of fewer pharmacies than they did just a decade ago.

The Leukemia & Lymphoma Society (LLS) Names Avella Executive Hamilton Baiden as the Corporate Walk Chair for Greater Phoenix Light The Night
March 29, 2018| CATEGORIES: Avella , Oncology , LLS , Press Release

Phoenix, AZ – The Arizona Chapter of The Leukemia & Lymphoma Society (LLS) announced today that Avella Specialty Pharmacy Executive Vice President Hamilton Baiden will serve as the Corporate Walk Chair of the 2018 Greater Phoenix Light The Night.

Improving medication adherence — something’s got to give
January 25, 2018| CATEGORIES: Adherence , Press Mention

Avella was recently featured in Pharmaceutical Commerce article for its work in medication adherence and technology. 

Poor adherence to prescribed medications creates one of today’s most pressing public health issues. When patients fail to take their medications as prescribed — either stopping before the course of treatment is complete, abandoning long-term therapies prescribed for chronic conditions, or taking the medications incorrectly — it creates far-reaching clinical and financial consequences for all stakeholders:

Abby Kaplan is Avella Specialty Pharmacy's Master of Acquisition
December 26, 2017| CATEGORIES: Avella , Press Feature

There are two main ways to expand a company,” says Avella Specialty Pharmacy’s Abby Kaplan. “You can do it organically, or you can do it through acquisition.” In 2016, Avella did both.

Smart Pill Bottles Among New Technologies Emerging to Boost Patient Outcomes
November 7, 2017| CATEGORIES: Adherence , Press Mention

Through emerging options that create automated processes to address prevention and wellness and increase accountability by the patient, specialty pharmacy has the ability to deliver greater value, said Eric Sredzinski, executive vice-president of clinical affairs and quality assurance with Avella Specialty Pharmacy.

Avella Is Now the Third Largest Privately-Held Company in the State According to the Arizona Corporate Excellence (ACE) Awards.
November 3, 2017| CATEGORIES: Avella , ACE Awards , Press Release

Phoenix, AZ -- Avella Specialty Pharmacy announced that it has been named the third largest privately-held company in the state by the Phoenix Business Journal through its Arizona Corporate Excellence (ACE) Awards. Avella moved up from its rank as the fourth largest in 2016 and was also recognized as the sixth fastest-growing company in Arizona this year.

Avella Selected by AstraZeneca to Distribute CALQUENCE® (acalabrutinib)
October 31, 2017| CATEGORIES: Oncology , Press Release

The specialty pharmacy will provide access to this FDA-approved, second-generation treatment for mantle cell lymphoma

News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.
Subscribe
Featured Video
Photo of Brian Halligan
Path of a Specialty Prescription
The path of a specialty prescription is complex. This video details each step of the path and the unique offerings of Avella.
News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.
Subscribe